Literature DB >> 24128723

In response.

Roland Hubaux1, Kelsie L Thu, Wan L Lam, Adjei Alex.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24128723      PMCID： PMC3925784          DOI： 10.1097/01.JTO.0000435739.64803.99

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  5 in total

1.  EZH2 promotes E2F-driven SCLC tumorigenesis through modulation of apoptosis and cell-cycle regulation.

Authors:  Roland Hubaux; Kelsie L Thu; Bradley P Coe; Calum MacAulay; Stephen Lam; Wan L Lam
Journal:  J Thorac Oncol       Date:  2013-08       Impact factor: 15.609

2.  miR-101 DNA copy loss is a prominent subtype specific event in lung cancer.

Authors:  Kelsie L Thu; Raj Chari; William W Lockwood; Stephen Lam; Wan L Lam
Journal:  J Thorac Oncol       Date:  2011-09       Impact factor: 15.609

3.  Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.

Authors:  Martin Peifer; Lynnette Fernández-Cuesta; Martin L Sos; Julie George; Danila Seidel; Lawryn H Kasper; Dennis Plenker; Frauke Leenders; Ruping Sun; Thomas Zander; Roopika Menon; Mirjam Koker; Ilona Dahmen; Christian Müller; Vincenzo Di Cerbo; Hans-Ulrich Schildhaus; Janine Altmüller; Ingelore Baessmann; Christian Becker; Bram de Wilde; Jo Vandesompele; Diana Böhm; Sascha Ansén; Franziska Gabler; Ines Wilkening; Stefanie Heynck; Johannes M Heuckmann; Xin Lu; Scott L Carter; Kristian Cibulskis; Shantanu Banerji; Gad Getz; Kwon-Sik Park; Daniel Rauh; Christian Grütter; Matthias Fischer; Laura Pasqualucci; Gavin Wright; Zoe Wainer; Prudence Russell; Iver Petersen; Yuan Chen; Erich Stoelben; Corinna Ludwig; Philipp Schnabel; Hans Hoffmann; Thomas Muley; Michael Brockmann; Walburga Engel-Riedel; Lucia A Muscarella; Vito M Fazio; Harry Groen; Wim Timens; Hannie Sietsma; Erik Thunnissen; Egbert Smit; Daniëlle A M Heideman; Peter J F Snijders; Federico Cappuzzo; Claudia Ligorio; Stefania Damiani; John Field; Steinar Solberg; Odd Terje Brustugun; Marius Lund-Iversen; Jörg Sänger; Joachim H Clement; Alex Soltermann; Holger Moch; Walter Weder; Benjamin Solomon; Jean-Charles Soria; Pierre Validire; Benjamin Besse; Elisabeth Brambilla; Christian Brambilla; Sylvie Lantuejoul; Philippe Lorimier; Peter M Schneider; Michael Hallek; William Pao; Matthew Meyerson; Julien Sage; Jay Shendure; Robert Schneider; Reinhard Büttner; Jürgen Wolf; Peter Nürnberg; Sven Perner; Lukas C Heukamp; Paul K Brindle; Stefan Haas; Roman K Thomas
Journal:  Nat Genet       Date:  2012-09-02       Impact factor: 38.330

4.  Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.

Authors:  Charles M Rudin; Steffen Durinck; Eric W Stawiski; John T Poirier; Zora Modrusan; David S Shames; Emily A Bergbower; Yinghui Guan; James Shin; Joseph Guillory; Celina Sanchez Rivers; Catherine K Foo; Deepali Bhatt; Jeremy Stinson; Florian Gnad; Peter M Haverty; Robert Gentleman; Subhra Chaudhuri; Vasantharajan Janakiraman; Bijay S Jaiswal; Chaitali Parikh; Wenlin Yuan; Zemin Zhang; Hartmut Koeppen; Thomas D Wu; Howard M Stern; Robert L Yauch; Kenneth E Huffman; Diego D Paskulin; Peter B Illei; Marileila Varella-Garcia; Adi F Gazdar; Frederic J de Sauvage; Richard Bourgon; John D Minna; Malcolm V Brock; Somasekar Seshagiri
Journal:  Nat Genet       Date:  2012-09-02       Impact factor: 38.330

5.  Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer.

Authors:  Bradley P Coe; Kelsie L Thu; Sarit Aviel-Ronen; Emily A Vucic; Adi F Gazdar; Stephen Lam; Ming-Sound Tsao; Wan L Lam
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.